Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-8-23
pubmed:abstractText
Small-bowel adenocarcinoma (SBA) is a rare tumor of poor prognosis. Data on the efficacy of chemotherapy for advanced SBA are scarce.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1786-93
pubmed:meshHeading
pubmed-meshheading:20223786-Adult, pubmed-meshheading:20223786-Aged, pubmed-meshheading:20223786-Aged, 80 and over, pubmed-meshheading:20223786-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20223786-Camptothecin, pubmed-meshheading:20223786-Cisplatin, pubmed-meshheading:20223786-Duodenal Neoplasms, pubmed-meshheading:20223786-Female, pubmed-meshheading:20223786-Fluorouracil, pubmed-meshheading:20223786-Follow-Up Studies, pubmed-meshheading:20223786-Humans, pubmed-meshheading:20223786-Ileal Neoplasms, pubmed-meshheading:20223786-Intestine, Small, pubmed-meshheading:20223786-Jejunal Neoplasms, pubmed-meshheading:20223786-Leucovorin, pubmed-meshheading:20223786-Liver Neoplasms, pubmed-meshheading:20223786-Lung Neoplasms, pubmed-meshheading:20223786-Lymphatic Metastasis, pubmed-meshheading:20223786-Male, pubmed-meshheading:20223786-Middle Aged, pubmed-meshheading:20223786-Neoplasm Staging, pubmed-meshheading:20223786-Organoplatinum Compounds, pubmed-meshheading:20223786-Peritoneal Neoplasms, pubmed-meshheading:20223786-Prognosis, pubmed-meshheading:20223786-Retrospective Studies, pubmed-meshheading:20223786-Survival Rate
pubmed:year
2010
pubmed:articleTitle
Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.
pubmed:affiliation
Department of Medical Oncology, Saint-Antoine Hospital, Assistance Publique Hôpitaux de Paris, University Paris VI, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study